Literature DB >> 26414232

Pituitary Apoplexy.

Claire Briet1, Sylvie Salenave1, Jean-François Bonneville1, Edward R Laws1, Philippe Chanson1.   

Abstract

Pituitary apoplexy, a rare clinical syndrome secondary to abrupt hemorrhage or infarction, complicates 2%-12% of pituitary adenomas, especially nonfunctioning tumors. Headache of sudden and severe onset is the main symptom, sometimes associated with visual disturbances or ocular palsy. Signs of meningeal irritation or altered consciousness may complicate the diagnosis. Precipitating factors (increase in intracranial pressure, arterial hypertension, major surgery, anticoagulant therapy or dynamic testing, etc) may be identified. Corticotropic deficiency with adrenal insufficiency may be life threatening if left untreated. Computed tomography or magnetic resonance imaging confirms the diagnosis by revealing a pituitary tumor with hemorrhagic and/or necrotic components. Formerly considered a neurosurgical emergency, pituitary apoplexy always used to be treated surgically. Nowadays, conservative management is increasingly used in selected patients (those without important visual acuity or field defects and with normal consciousness), because successive publications give converging evidence that a wait-and-see approach may also provide excellent outcomes in terms of oculomotor palsy, pituitary function and subsequent tumor growth. However, it must be kept in mind that studies comparing surgical approach and conservative management were retrospective and not controlled.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26414232     DOI: 10.1210/er.2015-1042

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  87 in total

Review 1.  Management of cystic prolactinomas: a review.

Authors:  Afif Nakhleh; Naim Shehadeh; Irit Hochberg; Moshe Zloczower; Sagit Zolotov; Riad Taher; Deeb Daoud Naccache
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

Review 2.  Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging.

Authors:  Amit Mahajan; Richard A Bronen; Ali Y Mian; Sacit Bulent Omay; Dennis D Spencer; Silvio E Inzucchi
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

3.  Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features.

Authors:  Yang Zhang; Chaoyue Chen; Zerong Tian; Jianguo Xu
Journal:  Jpn J Radiol       Date:  2020-07-25       Impact factor: 2.374

4.  Contribution of sellar dura integrity to symptom manifestation in pituitary adenomas with intratumoral hemorrhage.

Authors:  Yasuhiko Hayashi; Yasuo Sasagawa; Daisuke Kita; Issei Fukui; Masahiro Oishi; Osamu Tachibana; Fumiaki Ueda; Mitsutoshi Nakada
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

Review 5.  Imaging neurological emergencies in pregnancy and puerperium.

Authors:  Matthew A Haber; Diego Nunez
Journal:  Emerg Radiol       Date:  2018-07-20

6.  Pituitary Apoplexy With Bilateral Oculomotor Nerve Palsy.

Authors:  Sevan R Komshian; Ramin Saket; Khamid Bakhadirov
Journal:  Neurohospitalist       Date:  2018-05-07

7.  Pituitary apoplexy after regadenoson myocardial perfusion scan.

Authors:  Suchith Shetty; Joseph Gnanaraj; Sitalakshmi Jayamani Roshan; Ramzi El Accaoui
Journal:  J Nucl Cardiol       Date:  2018-08-30       Impact factor: 5.952

8.  A middle cerebral artery ischemic stroke occurring in a child with a large prolactinoma.

Authors:  Taemin Oh; Dominic Amara; Nalin Gupta; Patricia Clerkin
Journal:  Childs Nerv Syst       Date:  2019-12-18       Impact factor: 1.475

Review 9.  Neurological Complications of Endocrine Emergencies.

Authors:  Salvador Cruz-Flores
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-11       Impact factor: 5.081

10.  A retrospective review of 34 cases of pediatric pituitary adenoma.

Authors:  Nannan Zhang; Peizhi Zhou; Yu Meng; Feng Ye; Shu Jiang
Journal:  Childs Nerv Syst       Date:  2017-07-18       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.